Floatz logo

26 assets in Fibrolamellar Hepatocellular Carcinoma

Therapeutic assets addressing Fibrolamellar Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Irinotecan
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP3BB (66)
Fluorouracilum
Fibrolamellar Hepatocellular Carcinoma
M.D. Anderson Cancer CenterP3BB (64)
Nivolumab
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2B (63)
Sorafenib
Fibrolamellar Hepatocellular Carcinoma
St. Jude Children's Research HospitalP3B (62)
Adriamycin
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Carboplatin
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Cis-Diamminedichloroplatinum Ii
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Cyclophosphamide
Fibrolamellar Hepatocellular Carcinoma
St. Jude Children's Research HospitalP2B (60)
Etoposide
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Vincristine Sulfate
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Oxaliplatin
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP3B (56)
(-)-Sirpiglenastat
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2CCC (54)
Pembrolizumab
Fibrolamellar Hepatocellular Carcinoma
Allison O'Neill, MDP2CCC (53)
dt2216
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology GroupP1/2CCC (48)
Durvalumab
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2CCC (48)
Novaferon
Fibrolamellar Hepatocellular Carcinoma
M.D. Anderson Cancer CenterP1/2CCC (48)
Atezolizumab
Fibrolamellar Hepatocellular Carcinoma
St. Jude Children's Research HospitalP1/2CC (47)
Cobolimab
Fibrolamellar Hepatocellular Carcinoma
GlaxoSmithKlineP1/2CC (47)
Dostarlimab
Fibrolamellar Hepatocellular Carcinoma
GlaxoSmithKlineP1/2CC (47)
Kat-101
Fibrolamellar Hepatocellular Carcinoma
Primocure PharmaP1/2CC (47)
Kat-201
Fibrolamellar Hepatocellular Carcinoma
Primocure PharmaP1/2CC (47)
Balstilimab
Fibrolamellar Hepatocellular Carcinoma
Agenus Inc.P1CC (43)
Botensilimab
Fibrolamellar Hepatocellular Carcinoma
Agenus Inc.P1CC (43)
Dnajb1-Prkaca Peptide Vaccine
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1CC (43)
Fusion-Vac-Xs15
Fibrolamellar Hepatocellular Carcinoma
University Hospital TuebingenP1CC (43)
Ipilimumab
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1CC (43)